The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Podolsky, Craig
    Company Director born in February 1981
    Individual (10 offsprings)
    Officer
    2021-11-16 ~ now
    OF - Director → CIF 0
  • 2
    Jacobson, Ian
    Company Director born in March 1960
    Individual (12 offsprings)
    Officer
    2021-12-23 ~ now
    OF - Director → CIF 0
    Mr Ian Jacobson
    Born in March 1960
    Individual (12 offsprings)
    Person with significant control
    2021-11-16 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 3
    Fraser-pye, Graham Julian
    Company Director born in March 1968
    Individual (17 offsprings)
    Officer
    2022-05-07 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

LYRA PHARMA LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
196,236 GBP2023-12-31
120,315 GBP2022-12-31
Cash at bank and in hand
758,293 GBP2023-12-31
1,777,884 GBP2022-12-31
Current Assets
954,529 GBP2023-12-31
1,898,199 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-1,229,604 GBP2023-12-31
-1,283,530 GBP2022-12-31
Net Current Assets/Liabilities
-275,075 GBP2023-12-31
614,669 GBP2022-12-31
Equity
Called up share capital
23,950 GBP2023-12-31
23,950 GBP2022-12-31
Share premium
2,361,097 GBP2023-12-31
2,361,097 GBP2022-12-31
Retained earnings (accumulated losses)
-2,660,122 GBP2023-12-31
-1,770,378 GBP2022-12-31
Equity
-275,075 GBP2023-12-31
614,669 GBP2022-12-31
Average Number of Employees
02023-01-01 ~ 2023-12-31
02021-11-16 ~ 2022-12-31
Trade Debtors/Trade Receivables
Current
92,345 GBP2023-12-31
0 GBP2022-12-31
Other Debtors
Amounts falling due within one year
103,891 GBP2023-12-31
120,315 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
196,236 GBP2023-12-31
120,315 GBP2022-12-31
Trade Creditors/Trade Payables
Current
233,561 GBP2023-12-31
418,646 GBP2022-12-31
Other Creditors
Current
996,043 GBP2023-12-31
864,884 GBP2022-12-31
Creditors
Current
1,229,604 GBP2023-12-31
1,283,530 GBP2022-12-31

  • LYRA PHARMA LIMITED
    Info
    Registered number 13747076
    Cannon Place, 78 Cannon Street, London EC4N 6AF
    Private Limited Company incorporated on 2021-11-16 (3 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2023-11-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.